Senior Director, Global Oncology Health Economics Outcomes Research & Real-World Evidence in Basking Ridge at Daiichi Sankyo

Date Posted: 11/14/2022

Job Snapshot

  • Employee Type:
    Full-Time
  • Location:
    Basking Ridge
  • Experience:
    Not Specified
  • Date Posted:
    11/14/2022
  • Job ID:
    R1326

Job Description

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.


Summary


The purpose of this role is to develop and drive the Global HEOR and RWE strategies for the assigned oncology franchise products, in alignment with key global and regional functions. The Global Sr Director of HEOR & RWE Oncology will lead the HEOR and RWE asset team in the execution of the market access strategy and evidence generation activities across Daiichi-Sankyo. He/She will build and drive the asset specific HEOR strategy and coordinate all corresponding HEOR and RWE activities under the Global Oncology Value Access & Pricing department for the Oncology Business Unit, in collaboration with cross-functional teams. The role will be responsible for the HEOR and RWE strategy and tactical plans, including decision making and people management in the conduct of global health economic models, global value dossiers, RWE studies, PRO analysis, and will develop plans for innovative tools, methods, and strategies to ensure successful market access and support the company's vision of being a leader in oncology and deliver the innovative Daiichi Sankyo's treatments to patient. The Sr Director will direct and supervise evidence generation strategies and tactics, both through cross-functional teams and management of subordinates. Reports directly to the Vice President and Global Head of Oncology HEOR and RWE and has the responsibility to build a robust global HEOR/RWE strategy and manage team members and resources in order to execute on the strategy. The position will be a key and visible expert leader, he/she will engage the clinical, Medical Affairs and commercial organization and drive the product evidence strategies to ensure an effective use of HEOR and RWE methods. The Sr Director will provide HEOR and RWE strategic direction to Global Project Teams (GPTs) and Global Brand Teams (GBTs) and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic endpoints and patient-reported outcomes (PROs), ensuring the payer perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access is addressed. The Sr Director will help set up new strategies for the company and the HEOR team that will ensure a successful launch our oncology products. Lead the team through direct line management and arrange cross-functional working teams to drive process improvements and efficiencies. Furthermore, the role will develop HEOR sections in target product profiles (TPPs), product development plans, clinical development plans, and commercialization plans and other critical documents.

Responsibilities

- Direct the team to ensure cross-functional collaboration between Global Value Access and Pricing and other internal stakeholders such as Medical Affairs, Clinical Development, Marketing, Biostats, etc.
- Supervise the conduct of HEOR and RWE projects such as early economic models, burden of illness studies, external control arms to support single arm trials, and drive the development, analysis, and validation of patient-reported outcome (PRO) instruments in clinical trials
- Propose and drive the implementation of analysis of clinical trial data for cost effectiveness models and market specific ad-hoc requests for reimbursement submissions
- Assess RWE data gaps and building cross-functional evidence generation strategy for payers and reimbursement submissions
- Lead the team in the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and agreed/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products
- Oversee the implementation of literature reviews to build payer evidence, economic models, and Global Value Dossiers
- Direct and oversee the implementation of global cost effectiveness and budget impact models for HTA submissions to support reimbursement of indications for Daiichi Sankyo’s oncology products
- Decide on HEOR and RWE communications (e.g. manuscripts, scientific forum presentations, slide decks, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products
- Effectively manage external consultancies and contractors, ensuring delivery according to key milestones, budget and to agreed and expected quality
- Maintain and continue to enhance knowledge about HEOR methods and the evolving public health policy and reimbursement environment in major (USA, Europe and Japan) and other pertinent markets


Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.


Education Qualifications (from an accredited college or university)

- Bachelor's Degree required
- Master's Degree In a relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology) required or
- PhD In a relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology) required


Experience Qualifications

- 10 or More Years In the healthcare or pharmaceutical industry, 8 of which must be working in the HEOR field required
- Hands on experience with HEOR methodologies across all phases of the product life cycle preferred
- Track record of successful application of HEOR & RWE with key external stakeholders in major international markets preferred
- Knowledge and experience of Oncology therapy areas preferred


Travel

Ability to travel up to 30%


Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.